Reference intervals and discrimination values of the Lanthony desaturated D-15 panel test in young to middle-aged Japanese army officials: The Okubo Color Study Report 1

Eye

Volumn 23, Issue 6, 2009, Pages 1329-1335

  Shoji, T ^a,b,c   Sakurai, Y ^c   Chihara, E ^b   Nishikawa, S ^c   Omae, K ^a  

^a KEIO UNIVERSITY   (Japan)

^b Sensho kai Eye Institute   (Japan)

^c NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Colour confusion index; Colour discrimination function; Discrimination value; Farnsworth Munsell 100 hue test; Lanthony desaturated D 15 pane test; Reference interval

Indexed keywords

ADULT; AGED; AREA UNDER THE CURVE; ARMY; ARTICLE; BOWMAN COLOUR CONFUSION INDEX; CALCULATION; COLOR VISION; COLOR VISION DEFECT; COLOR VISION TEST; CONFIDENCE INTERVAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EYE DISEASE; FARNSWORTH MUNSELL; GROUPS BY AGE; HUMAN; INTERVIEW; ISHIHARA PSEUDOISOCHROMATIC PLATES; JAPANESE; LANTHONY DESATURATED D 15 PANEL TEST; MALE; MATHEMATICAL ANALYSIS; MEDICAL RECORD; POPULATION; QUANTITATIVE ANALYSIS; REFERENCE VALUE; SCREENING; SENSITIVITY AND SPECIFICITY;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; COLOR PERCEPTION; COLOR PERCEPTION TESTS; COLOR VISION DEFECTS; DISCRIMINATION (PSYCHOLOGY); HUMANS; JAPAN; MALE; MIDDLE AGED; MILITARY PERSONNEL; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 67650678405     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.292     Document Type: Article

References (27)

1. Verriest G, Van Laethem J, Uvijls A. A new assessment of the normal ranges of the Farnsworth-Munsell 100-hue test scores. Am J Ophthalmol 1982; 93: 635-642.
2. Mantyjarvi M. Normal test scores in the Farnsworth- Munsell 100-hue test. Doc Ophthalmol 2001; 102: 73-80.
3. Roy MS, Podgor MJ, Collier B, Gunkel RD. Color vision and age in a normal North American population. Graefes Arch Clin Exp Ophthalmol 1991; 229: 139-144.
4. Gobba F, Cavalleri A. Color vision impairment in workers exposed to neurotoxic chemicals. Neurotoxicology 2003; 24: 693-702.
5. Gobba F, Cavalleri A. Evolution of color vision loss induced by occupational exposure to chemicals. Neurotoxicology 2000; 21: 777-781.
6. Iregren A, Andersson M, Nylen P. Color vision and occupational chemical exposures: I. An overview of tests and effects. Neurotoxicology 2002; 23: 719-733. Review.
7. Urban P, Gobba F, Nerudova J, Lukas E, Cabelkova Z, Cikrt M. Color discrimination impairment in workers exposed to mercury vapor. Neurotoxicology 2003; 24: 711-716.
8. Gobba F. Related Color vision: a sensitive indicator of exposure to neurotoxins. Neurotoxicology 2000; 21: 857-862.
9. Farnsworth D. The Farnsworth-Munsell 100-Hue Test Manual (Revised). Munsell Color Co.: Baltimore, 1957.
10. Fong DS, Barton FB, Bresnick GH. Impaired color vision associated with diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report No. 15. Am J Ophthalmol 1999; 128: 612-617.
11. Bowman KJ. A method for quantitative scoring of the Farnsworth Panel D-15. Acta Ophthalmol (Copenh) 1982; 60: 907-916.
12. Vingrys AJ, King-Smith PE. A quantitative scoring technique for panel tests of color vision. Invest Ophthalmol Vis Sci 1988; 29: 50-63.
13. Bassi CJ, Galanis JC, Hoffman J. Comparison of the Farnsworth-Munsell 100-Hue, the Farnsworth D-15, and the L'Anthony D-15 desaturated color tests. Arch Ophthalmol 1993; 111: 639-641.
14. Good GW, Schepler A, Nichols JJ. The reliability of the lanthony desaturated D-15 test. Optom Vis Sci 2005; 82: 1054-1059.
15. Iregren A, Andersson M, Nylen P. Color vision and occupational chemical exposures. II. Visual functions in non-exposed subjects. Neurotoxicology 2002; 23: 735-745.
16. Melamud A, Hagstrom S, Traboulsi E. Color vision testing. Ophthalmic Genet 2004; 25: 159-187.
17. Vu BL, Easterbrook M, Hovis JK. Detection of color vision defects in chloroquine retinopathy. Ophthalmology 1999; 106: 1799-1803.
18. Gobba F, Cavalleri A. Color vision impairment in workers exposed to neurotoxic chemicals. Neurotoxicology 2003; 24: 693-702.
19. Lawrenson JG, Kelly C, Lawrenson AL, Birch J. Acquired colour vision deficiency in patients receiving digoxin maintenance therapy. Br J Ophthalmol 2002; 86: 1259-1261.
20. Third Report of the National Cholesterol Education Panel (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel or ATP III). NIH Publication No. 01-3305 May 2001.
21. American Diabetes Association. Standards of medical care in diabetes-2006. Diabetes Care 2006; 29(Suppl 1): S4-S42.
22. Kessel L, Alsing A, Larsen M. Diabetic versus non-diabetic colour vision after cataract surgery. Br J Ophthalmol 1999; 83: 1042-1045.
23. Cavalleri A, Gobba F, Nicali E, Fiocchi V. Dose-related color vision impairment in toluene-exposed workers. Arch Environ Health 2000; 55: 399-404.
24. Alcala A, Morell M, Rius F. Comparative study of the impact of diet versus pravastatin on color vision in Brodman area 19 detected by computerized chromatic analysis (CARDIOCOLOUR Study). Rev Esp Cardiol 2002; 55: 1243-1250.
25. Ihrig A, Nasterlack M, Dietz MC, Hoffmann J, Triebig G. Pilot study on prevalence of color vision dysfunction in long-term solvent-exposed painters. Ind Health 2003; 41: 39-42.
26. Woo GC. Are ethnic differences in the F-M 100 scores related to macular pigmentation? Clin Exp Optom 2002; 85: 372-377.
27. Baird B, Camp J, Daniell W, Antonelli J. Solvents and color discrimination ability. Nonreplication of previous findings. J Occup Med 1994; 36: 747-751.